Bambusa Therapeutics, Inc. (BBTX)

NASDAQ: BBTX · Real-Time Price · USD

17.50

+0.34 (1.98%)

Nov 12, 2026, 9:36 AM EST - Market open

Bambusa Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Nov '26 Nov 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Market Capitalization	891	-	-
Market Cap Growth	-	-	-
Enterprise Value	820	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Nov '26 Nov 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Net Debt / Equity Ratio	-1.09	-1.05	-20.90
Quick Ratio	5.95	9.59	1.01
Current Ratio	6.16	9.76	1.05
Return on Equity (ROE)	-	-94.98%	-
Return on Assets (ROA)	-	-48.23%	-
Return on Capital Employed (ROCE)	-75.10%	-47.30%	-3717.90%

SEC Filings: 10-K · 10-Q